Literature DB >> 2563835

Congenital renal dysgenesis possibly due to captopril.

P D Knott, S S Thorpe, C A Lamont.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563835     DOI: 10.1016/s0140-6736(89)90058-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Dependence of renal microvessel density on angiotensin II: only in the fetus?

Authors:  Barbara J Ballermann
Journal:  J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 10.121

2.  Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

Authors:  L A Magee; G Inocencion; L Kamboj; F Rosetti; G Koren
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

3.  Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists.

Authors:  Farida Daïkha-Dahmane; Evelyne Levy-Beff; Myriam Jugie; Richard Lenclen
Journal:  Pediatr Nephrol       Date:  2006-03-25       Impact factor: 3.714

Review 4.  An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.

Authors:  H S Buttar
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

5.  Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep.

Authors:  K M Stevenson; K J Gibson; E R Lumbers
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: a case report and review of the literature.

Authors:  Eleni Georgaki-Angelaki; Nicolaos Stergiou; Ekaterini Naoum; Ioannis Papassotiriou; Marina Anagnostakou
Journal:  NDT Plus       Date:  2009-04-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.